This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Rebecca Voelker

JAMA. 1999;282:933.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

International public health authorities have signaled the need for greater vigilance in controlling drug-resistant and drug-susceptible tuberculosis (TB) in Russia.

In the August 6 Morbidity and Mortality Weekly Report, investigators from the World Health Organization, the US Centers for Disease Control and Prevention, and other institutions reported on a substantial increase in primary multidrug-resistant TB (P-MDRTB) in Ivanovo oblast, a district of 1.3 million people about 165 miles northeast of Moscow. Despite implementation of short-course directly observed therapy in 1995 in Ivanovo, the percentage of new cases that were identified as P-MDRTB increased from 3.8% in 1996 to 9.4% in 1998. The investigation also showed that patients with resistant and susceptible TB had high rates of previous incarceration, unemployment, alcoholism, and homelessness.

Investigators recommended that Ivanovo's TB control program must target high-risk populations, implement rapid drug susceptibility testing, and use appropriate second-line TB drugs for patients with . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?